Annual Long Term Debt
$936.00 K
-$324.00 K-25.71%
31 December 2023
Summary:
Viking Therapeutics annual long term debt is currently $936.00 thousand, with the most recent change of -$324.00 thousand (-25.71%) on 31 December 2023. During the last 3 years, it has risen by +$907.00 thousand (+3127.59%). VKTX annual long term debt is now -56.50% below its all-time high of $2.15 million, reached on 31 December 2015.VKTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$755.00 K
-$11.00 K-1.44%
30 September 2024
Summary:
Viking Therapeutics quarterly long term debt is currently $755.00 thousand, with the most recent change of -$11.00 thousand (-1.44%) on 30 September 2024. Over the past year, it has dropped by -$263.00 thousand (-25.83%). VKTX quarterly long term debt is now -79.67% below its all-time high of $3.71 million, reached on 31 March 2017.VKTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -25.7% | -25.8% |
3 y3 years | +3127.6% | +100.0% |
5 y5 years | +100.0% | +72.4% |
VKTX Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -25.7% | -49.3% | ||
5 y | 5 years | -25.7% | -49.3% | ||
alltime | all time | -56.5% | -79.7% |
Viking Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $755.00 K(-1.4%) |
June 2024 | - | $766.00 K(-10.1%) |
Mar 2024 | - | $852.00 K(-9.0%) |
Dec 2023 | $936.00 K(-25.7%) | $936.00 K(-8.1%) |
Sept 2023 | - | $1.02 M(-7.5%) |
June 2023 | - | $1.10 M(-6.9%) |
Mar 2023 | - | $1.18 M(-6.3%) |
Dec 2022 | $1.26 M(>+9900.0%) | $1.26 M(-5.8%) |
Sept 2022 | - | $1.34 M(-5.4%) |
June 2022 | - | $1.41 M(-5.1%) |
Mar 2022 | - | $1.49 M(>+9900.0%) |
Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2021 | - | $0.00(0.0%) |
June 2021 | - | $0.00(0.0%) |
Mar 2021 | - | $0.00(-100.0%) |
Dec 2020 | $29.00 K | $29.00 K(-74.8%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $115.00 K(-41.9%) |
June 2020 | - | $198.00 K(-29.0%) |
Mar 2020 | - | $279.00 K(-22.5%) |
Dec 2019 | $360.00 K(>+9900.0%) | $360.00 K(-17.8%) |
Sept 2019 | - | $438.00 K(-14.6%) |
June 2019 | - | $513.00 K(-12.8%) |
Mar 2019 | - | $588.00 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Mar 2017 | - | $3.71 M(+18.3%) |
Mar 2016 | - | $3.14 M(+45.9%) |
Dec 2015 | $2.15 M(+70.2%) | $2.15 M(+50.5%) |
Mar 2015 | - | $1.43 M(+13.1%) |
Dec 2014 | $1.26 M(+445.1%) | $1.26 M(+294.7%) |
June 2014 | - | $320.30 K(+35.0%) |
Mar 2014 | - | $237.20 K |
Dec 2013 | $231.90 K(+441.8%) | - |
Dec 2012 | $42.80 K | - |
FAQ
- What is Viking Therapeutics annual long term debt?
- What is the all time high annual long term debt for Viking Therapeutics?
- What is Viking Therapeutics annual long term debt year-on-year change?
- What is Viking Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Viking Therapeutics?
- What is Viking Therapeutics quarterly long term debt year-on-year change?
What is Viking Therapeutics annual long term debt?
The current annual long term debt of VKTX is $936.00 K
What is the all time high annual long term debt for Viking Therapeutics?
Viking Therapeutics all-time high annual long term debt is $2.15 M
What is Viking Therapeutics annual long term debt year-on-year change?
Over the past year, VKTX annual long term debt has changed by -$324.00 K (-25.71%)
What is Viking Therapeutics quarterly long term debt?
The current quarterly long term debt of VKTX is $755.00 K
What is the all time high quarterly long term debt for Viking Therapeutics?
Viking Therapeutics all-time high quarterly long term debt is $3.71 M
What is Viking Therapeutics quarterly long term debt year-on-year change?
Over the past year, VKTX quarterly long term debt has changed by -$263.00 K (-25.83%)